Package 31722-019-31

{"route": ["ORAL", "RECTAL"], "spl_id": "2e7917f2-e573-cccb-e063-6294a90a203c", "openfda": {"upc": ["0331722019125", "0331722019309", "0331722019316"], "unii": ["3X9MR4N98U", "V5403H8VG7"], "spl_set_id": ["a216a7d5-3c28-482b-956a-93ae146e3763"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "24 BOTTLE in 1 BOX (31722-019-31)  / 30 mL in 1 BOTTLE (31722-019-30)", "package_ndc": "31722-019-31", "marketing_start_date": "20231117"}, {"sample": false, "description": "12 BOTTLE in 1 BOX (31722-019-32)  / 120 mL in 1 BOTTLE (31722-019-12)", "package_ndc": "31722-019-32", "marketing_start_date": "20231117"}], "brand_name": "Diatrizoate Meglumine and Diatrizoate Sodium", "product_id": "31722-019_2e7917f2-e573-cccb-e063-6294a90a203c", "dosage_form": "SOLUTION", "pharm_class": ["Radiographic Contrast Agent [EPC]", "Radiographic Contrast Agent [EPC]", "X-Ray Contrast Activity [MoA]", "X-Ray Contrast Activity [MoA]"], "product_ndc": "31722-019", "generic_name": "Diatrizoate Meglumine and Diatrizoate Sodium", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diatrizoate Meglumine and Diatrizoate Sodium", "active_ingredients": [{"name": "DIATRIZOATE MEGLUMINE", "strength": "660 mg/mL"}, {"name": "DIATRIZOATE SODIUM", "strength": "100 mg/mL"}], "application_number": "ANDA215049", "marketing_category": "ANDA", "marketing_start_date": "20231117", "listing_expiration_date": "20261231"}